REMCARE: reminiscence groups for people with dementia and their family caregivers – effectiveness and cost-effectiveness pragmatic multicentre randomised trial
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: The aim of the REMiniscence groups for people with dementia and their family CAREgivers (REMCARE) study was to assess the effectiveness and cost-effectiveness of joint reminiscence groups for people with dementia and their family caregivers as compared with usual care. DESIGN: A multicentre, pragmatic randomised controlled trial with two parallel arms - an intervention group and a usual-care control group - was carried out. A restricted dynamic method of randomisation was used with an overall allocation ratio of 1 : 1, restricted to ensure intervention groups of a viable size. Assessments, blind to treatment allocation, were carried out at baseline, 3 months and 10 months (primary end point). SETTING: Most participants were recruited through NHS Memory Clinics and Community Mental Health Teams for older people. Assessments were usually carried out in the person's home, and treatment groups were held in a variety of community settings. PARTICIPANTS: A total of 488 individuals (mean age 77.5 years) with mild to moderate dementia (meeting Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition criteria), who were initially living in the community, and who had a relative or other caregiver maintaining regular contact, who could act as an informant and was willing and able to participate in the intervention, were recruited to the study. Most carers were spouses (71%). A total of 350 dyads completed the study. INTERVENTIONS: The intervention consisted of joint reminiscence groups held weekly for 12 consecutive weeks, followed by monthly maintenance sessions for a further 7 months. The sessions followed a treatment manual, and were led by two trained facilitators in each centre, supported by a number of volunteers. Up to 12 dyads were invited to attend each group. MAIN OUTCOME MEASURES: The primary outcome measures were self-reported quality of life for the person with dementia and psychological distress for the carer [General Health Questionnaire-28 item version (GHQ-28)]. Secondary outcome measures included autobiographical memory and activities of daily living for the person with dementia, carer stress for the carer and mood, relationship quality and service use and costs for both parties. RESULTS: The intention-to-treat analysis identified no differences in outcome between the intervention and control conditions on primary or secondary outcomes [self-reported quality of life in Alzheimer's disease: mean difference 0.07, standard error (SE) 0.65; F = 0.48; p = 0.53]. Carers of people with dementia allocated to the reminiscence intervention reported a significant increase in anxiety on a subscale of the GHQ-28 at the 10-month end point (mean difference 1.25, SE 0.5; F = 8.28; p = 0.04). Compliance analyses suggested some benefits for people with dementia who attended more reminiscence sessions; however, carers attending more groups showed increased caregiving stress. Use of health- and social-care services was modest, with no significant difference in service use between conditions. Owing to negligible difference in quality-adjusted life-year gains (derived from European Quality of Life-5 Dimensions) between the conditions the planned full economic analysis was curtailed. CONCLUSIONS: This trial does not provide support for the effectiveness or cost-effectiveness of joint reminiscence groups for people with dementia and their carers. Although there may be some beneficial effects for people with dementia who attend sessions as planned, this must be viewed in the context of raised anxiety and stress in their carers. The reasons for these discrepant outcomes need to be explored further, and may necessitate reappraisal of the movement towards joint interventions. TRIAL REGISTRATION: Current Controlled Trials ISRCTN42430123. FUNDING: This project was funded by the NIHR Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 16, No. 48. See the HTA programme website for further project information.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Development and validation of a geriatric depression screening scale: a preliminary report
Yesavage, J. A., Brink, T. L., Rose, T. L., Lum, O., Huang, V., Adey, M., & Leirer, V. O. (1982) · Journal of Psychiatric Research · doi:10.1016/0022-3956(82)90033-4 · Cited by 15,025
A New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
Cornell scale for depression in dementia
Alexopoulos, G. S., Abrams, R. C., Young, R. C., & Shamoian, C. A. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90038-8 · Cited by 2,678
Assessing Quality of Life in Older Adults With Cognitive Impairment
Logsdon, R. G., Gibbons, L. E., McCurry, S. M., & Teri, L. (2002) · Psychosomatic Medicine · doi:10.1097/00006842-200205000-00016 · Cited by 1,381 · cited 2×
“CSDD – person with dementia < 6 Absence of depressive symptoms 190/395 (48) 101/215 (47) 89/180 (49) > 10 Probable major depression 85/395 (22) 48/215 (22) 37/180 (21) > 18 Definite major depression 11/395 (3) 4/215 (2) 7/180 (4) RAID – person with dementia ≥ 11 Significant clinical anxiety 130/425 (31) 67/234 (29) 63…”
Meta‐Analysis of Psychosocial Interventions for Caregivers of People with Dementia
Brodaty, H., Green, A., & Koschera, A. (2003) · Journal of the American Geriatrics Society · doi:10.1034/j.1600-0579.2003.00210.x · Cited by 952 · cited 7×
“were made up of son/daughter (96), son/daughter-in-law (5), brother/sister (7), other relative (4), friend (15), partner (11), foster carer (1), carer (1), spouse–separated (1) and missing (1 randomised as other).”
BackgroundMethodInfluentialNonpharmacological therapies in Alzheimer’s disease: a systematic review of efficacy
Olazarán, J., Reisberg, B., Clare, L., Cruz, I., Peña-Casanova, J., del Ser, T., Woods, B., Beck, C., Auer, S., Lai, C., et al. (2010) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000316119 · Cited by 937
Cognitive stimulation to improve cognitive functioning in people with dementia
Woods, B., Aguirre, E., Spector, A. E., & Orrell, M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005562.pub2 · Cited by 855 · cited 1×
“Alzheimer’s 106/183 (58) 58/105 (55) 48/78 (62) Vascular 23/183 (13) 15/105 (14) 8/78 (10) Lewy body 1/183 (< 1) 0/105 1/78 (1) Mixed Alzheimer’s and vascular 17/183 (9) 11/105 (10) 6/78 (8) Not known 36/183 (20) 21/105 (20) 15/78 (19)”
Self-citationLivingston, G., Johnston, K., Katona, C., Paton, J., Lyketsos, C. G., & Old Age Task Force of the World Federation of Biological Psychiatry (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.11.1996 · Cited by 591 · cited 4×
“HADS (depression) – carer ≥ 8 Mild disturbance 60/483 (12) 28/266 (11) 32/217 (15) ≥ 11 Moderate disturbance 24/483 (5) 14/266 (5) 10/217 (5) ≥ 15 Severe disturbance 4/483 (1) 4/266 (2) 0/217 (0) HADS (anxiety) – carer ≥ 8 Mild disturbance 92/483 (19) 53/266 (20) 39/217 (18) ≥ 11 Moderate disturbance 72/483 (15) 42/26…”
BackgroundInfluentialClare, L., & Woods, B. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003260 · Cited by 576 · cited 3×
“were made up of son/daughter (96), son/daughter-in-law (5), brother/sister (7), other relative (4), friend (15), partner (11), foster carer (1), carer (1), spouse–separated (1) and missing (1 randomised as other).”
BackgroundSelf-citationBefriending carers of people with dementia: randomised controlled trial
Charlesworth, G., Shepstone, L., Wilson, E., Reynolds, S., Mugford, M., Price, D., Harvey, I., & Poland, F. (2008) · BMJ · doi:10.1136/bmj.39549.548831.ae · Cited by 77 · cited 1×
“Bangor 71 64 (90) 59 (83) Bradford 50 46 (92) 42 (84) Hull 66 53 (80) 53 (80) London (north) 96 73 (76) 62 (65) London (south) 90 62 (69) 50 (56) Manchester 88 78 (87) 68 (77) Newport 26 19 (73) 16 (62) Total 487 395 (81) 350 (72)”
Cited by
Reminiscence therapy for dementia
Woods, B., O'Philbin, L., Farrell, E. M., Spector, A. E., & Orrell, M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001120.pub3 · Cited by 782
Self-citationMartyr, A., Nelis, S. M., Quinn, C., Wu, Y.-T., Lamont, R. A., Henderson, C., Clarke, R., Hindle, J. V., Thom, J. M., Jones, I. R., et al. (2018) · Psychological Medicine · doi:10.1017/s0033291718000405 · Cited by 311
Watt, J. A., Goodarzi, Z., Veroniki, A. A., Nincic, V., Khan, P. A., Ghassemi, M., Lai, Y., Treister, V., Thompson, Y., Schneider, R., et al. (2021) · BMJ · doi:10.1136/bmj.n532 · Cited by 143
Nickel, F., Barth, J., & Kolominsky-Rabas, P. L. (2018) · BMC Geriatrics · doi:10.1186/s12877-018-0751-1 · Cited by 58
“Further, an instructed walking program for PwDs and their caregivers is potentially cost-effective compared to CAU, when focusing on the reduction of BPSD as the outcome of interest [28].”
BackgroundResultInfluentialTonga, J. B., Šaltytė Benth, J., Arnevik, E. A., Werheid, K., Korsnes, M. S., & Ulstein, I. D. (2021) · International Psychogeriatrics · doi:10.1017/s1041610220000216 · Cited by 42
Metadata
- Authors
- Woods, R., Bruce, E., Edwards, R., Elvish, R., Hoare, Z., Hounsome, B., Keady, J., Moniz-Cook, E., Orgeta, V, Orrell, M., Rees, J., & Russell, I.
- Venue
- Health Technology Assessment
- Published
- 2012-12
- Volume
- 16
- Issue
- 48
- Pages
- v-xv, 1
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W1985068883
- Cited by
- 153
- References
- 10
- FWCI
- 7.17
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.